No retraction, correction or concern found when last checked on Oct 31, 2026.
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
Annachiara Rosa, Valerie E. Pye, Carl Graham and 37 more
Science Advances · 2021 · CC BY
doi:10.1101/2021.01.21.21249203
Abstract
SARS-CoV-2 spike N-terminal domain harbors a potent epitope that can be modulated by binding of natural linear tetrapyrroles.
Cited by papers we hold 4
- TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry · 2023No notice
- Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 · 2022No notice
- Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection · 2022No notice
- Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.